CNP(CNP)
CNP
Q4 2026 EPS Estimate
$0.52
Oct 22, 2026 · Reports before open
Revenue Estimate
$2.17B
FY2026E EPS$1.91
FY2027E EPS$2.09
Analyst Sentiment
Wall St. Consensus
Hold22 analysts·High coverage
60
Score
10 Buy (45%)11 Hold (50%)1 Sell (5%)
Rating Breakdown
Strong Buy
00%
Buy
1045%
Hold
1150%
Sell
15%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$40.00
-1.5%
Consensus
$46.00
+13.2%
Bull
$50.00
+23.1%
12-Month Target Range22 analysts
$40.00$46.00$50.00
Current $40.62Consensus
Current Price
$40.62
Upside to Consensus
$5.38
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.99%
EPS+9.21%
FY2028
Rev+4.98%
EPS+9.13%
FY2029
Rev+6.40%
EPS+8.58%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $9.92B | $10.32B | $10.83B | $11.53B | $12.07B |
| Low | $9.75B | $10.16B | $9.41B | $10.64B | $11.15B |
| High | $10.17B | $10.58B | $12.34B | $12.84B | $13.45B |
| EBITDA Avg | $4.84B | $5.03B | $5.28B | $5.62B | $5.89B |
| Low | $4.75B | $4.95B | $4.59B | $5.19B | $5.43B |
| High | $4.96B | $5.16B | $6.01B | $6.26B | $6.56B |
| EBIT Avg | $3.07B | $3.20B | $3.36B | $3.57B | $3.74B |
| Low | $3.02B | $3.15B | $2.91B | $3.30B | $3.45B |
| High | $3.15B | $3.28B | $3.82B | $3.98B | $4.17B |
| Net Income Avg | $1.25B | $1.36B | $1.50B | $1.62B | $1.76B |
| Low | $1.25B | $1.33B | $1.46B | $1.46B | $1.59B |
| High | $1.26B | $1.38B | $1.55B | $1.86B | $2.03B |
| EPS Avg | $1.91 | $2.09 | $2.28 | $2.47 | $2.69 |
| Low | $1.90 | $2.03 | $2.23 | $2.23 | $2.42 |
| High | $1.92 | $2.11 | $2.36 | $2.84 | $3.09 |
| Analysts (Rev / EPS) | 10 / 11 | 9 / 12 | 11 / 7 | 5 / 2 | 5 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.17B | $2.50B | $2.81B | $2.09B | $2.36B | $2.76B | $2.92B | $2.11B |
| Low | $2.12B | $2.45B | $2.68B | $1.99B | $2.25B | $2.63B | $2.78B | $2.01B |
| High | $2.24B | $2.56B | $2.90B | $2.16B | $2.44B | $2.85B | $3.02B | $2.18B |
| EBITDA Avg | $1.06B | $1.22B | $1.37B | $1.02B | $1.15B | $1.34B | $1.42B | $1.03B |
| Low | $1.03B | $1.20B | $1.30B | $971M | $1.10B | $1.28B | $1.36B | $980M |
| High | $1.09B | $1.25B | $1.41B | $1.05B | $1.19B | $1.39B | $1.47B | $1.06B |
| EBIT Avg | $671M | $776M | $870M | $647M | $731M | $854M | $905M | $653M |
| Low | $655M | $760M | $829M | $617M | $696M | $814M | $862M | $623M |
| High | $693M | $794M | $899M | $669M | $755M | $882M | $935M | $675M |
| Net Income Avg | $337M | $306M | $399M | $290M | $366M | $351M | $450M | $296M |
| Low | $311M | $238M | $375M | $272M | $344M | $330M | $423M | $278M |
| High | $376M | $340M | $416M | $302M | $382M | $366M | $470M | $309M |
| EPS Avg | $0.51 | $0.46 | $0.60 | $0.43 | $0.55 | $0.53 | $0.68 | $0.44 |
| Low | $0.47 | $0.36 | $0.56 | $0.41 | $0.52 | $0.50 | $0.63 | $0.42 |
| High | $0.56 | $0.51 | $0.63 | $0.45 | $0.57 | $0.55 | $0.71 | $0.46 |
| Analysts (Rev / EPS) | 3 / 8 | 3 / 8 | 1 / 3 | 1 / 4 | 1 / 3 | 1 / 4 | 1 / 4 | 1 / 5 |